Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Drug Development

MS Research Roundup: October 16, 2015

Research Roundup logo
Highlights from the 2015 meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona: B-Cell Bashing Ocrelizumab; New Outcome Measure for Daclizumab
Items of interest in multiple sclerosis research from around the Web...
Clinical Research, Drug Development, Meetings

PodBlog: Status of Stem Cell Therapies for MS

MSDF Podcast logo
Episode 55 of the MSDF podcast features Michael Levy, MD, PhD, of Johns Hopkins University School of Medicine, who discusses the status of regenerative stem cell therapies for multiple sclerosis.
Episode 55 of the MSDF podcast is out. Check it out. The podcast features an interview with...
Clinical Research, Drug Development, Laboratory Research, Meetings, People

Episode 51 with Dr. Luke Lairson on discovery of small molecules to induce remyelination

MSDF interviews Luke Lairson PhD of The Scripps Research Institute and the California Institute for Biomedical Research about a drug screen to find potential remyelination compounds and the strategy for researching their potential usefulness as candidate drugs to repair tissue damage in MS.
Links to articles and other resources mentioned in Episode 51
Drug Development, Laboratory Research, Methods

Refined Animal Model Led to Phenytoin Clinical Trial

Katie Lidster
In 2010, Professor David Baker was awarded an NC3Rs Project Grant to develop a...
An animal model that presents an alternative to EAE suggested a role for sodium channel blockers in neuroprotection. This led directly to a successful human trial of phenytoin, which was presented at last week’s AAN meeting.
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods

Seeking Answers for Progressive MS

International Progressive MS Alliance logo
An invitational meeting in Boston marks a step forward in a concerted international push to find effective therapies to target disease mechanisms, manage symptoms, and improve rehabilitation
A meeting in Boston early in March drew more than 80 scientists and clinical researchers to address...
Clinical Research, Drug Development, Laboratory Research, Meetings

Help Keep MSDF Alive!

Click Here to Support MSDF
Do you find MSDF invaluable? If so, please help us continue by making a tax-deductible donation NOW.
If you’re reading this message, it’s because you’re one of the 16,000 unique...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People


Subscribe to RSS - Drug Development